Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Drug Delivery: Multidrug Resistance in Cancer Circumvented Using a Cytosolic Drug Reservoir (Adv. Sci. 2/2018)
Advanced Science ( IF 14.3 ) Pub Date : 2018-02-27 , DOI: 10.1002/advs.201870006 Li Fan 1 , Silu Zhang 2, 3 , Chunyuan Zhang 4 , Chun Yin 4 , Zhiqin Chu 2 , Chaojun Song 5 , Ge Lin 4 , Quan Li 2
Advanced Science ( IF 14.3 ) Pub Date : 2018-02-27 , DOI: 10.1002/advs.201870006 Li Fan 1 , Silu Zhang 2, 3 , Chunyuan Zhang 4 , Chun Yin 4 , Zhiqin Chu 2 , Chaojun Song 5 , Ge Lin 4 , Quan Li 2
Affiliation
The sustained release of drug at adequate and stable cytosolic drug concentrations is found to be a feasible scheme to circumvent the multidrug resistance effect and serves as a promising guideline for drug design to overcome drug resistance in cancer therapeutics. In article number 1700289, Quan Li and co‐workers demonstrate the feasibility of using self‐decomposable nanoparticle drug carriers as intracellular drug reservoirs that enable delivery of a stable therapeutic concentration, leading to complete reversal of multidrug resistance.
中文翻译:
药物输送:使用细胞溶质药库规避了癌症的多药耐药性(Adv。Sci。2/2018)
发现在适当和稳定的胞质药物浓度下持续释放药物是避免多药耐药作用的可行方案,并为克服癌症治疗方法中的耐药性的药物设计提供了有希望的指导。在1700289号文章中,Quan Li及其同事证明了使用可自分解的纳米颗粒药物载体作为细胞内药物储库的可行性,该药物储库能够提供稳定的治疗浓度,从而完全逆转了多药耐药性。
更新日期:2018-02-27
中文翻译:
药物输送:使用细胞溶质药库规避了癌症的多药耐药性(Adv。Sci。2/2018)
发现在适当和稳定的胞质药物浓度下持续释放药物是避免多药耐药作用的可行方案,并为克服癌症治疗方法中的耐药性的药物设计提供了有希望的指导。在1700289号文章中,Quan Li及其同事证明了使用可自分解的纳米颗粒药物载体作为细胞内药物储库的可行性,该药物储库能够提供稳定的治疗浓度,从而完全逆转了多药耐药性。